Company Filing History:
Years Active: 1990-1992
Title: Reinhold Weidner: Innovator in Cardiotonic Compounds
Introduction
Reinhold Weidner is a notable inventor based in Nuremberg, Germany. He has made significant contributions to the field of cardiology through his innovative work in developing new therapeutic compounds. With two patents to his name, Weidner's research has a profound impact on heart disease treatment.
Latest Patents
Weidner's latest patents include the creation of cardiotonic thiadiazine derivatives. These new diazine derivatives, which correspond to a specific general formula, demonstrate promising qualities as positive inotropic compounds. They exhibit a higher and more selective action compared to previously known compounds, making them suitable for the treatment and prevention of various heart and circulation diseases.
Another significant patent involves the development of 6-oxo-pyridazine derivatives. This innovation presents a new line of positive inotropic compounds that also show enhanced activity in increasing inotropy. The patent details a preparation process and highlights the medical applications of these compounds or medications containing them.
Career Highlights
Reinhold Weidner is affiliated with Heumann Pharma GmbH & Co., a company dedicated to advancing pharmaceutical innovations. Throughout his career, he has focused on identifying and developing new compounds to address critical health issues, particularly in the field of cardiology.
Collaborations
While working at Heumann Pharma, Weidner has collaborated with colleagues such as Peter Morsdorf and Rolf Herter. These partnerships highlight the collaborative spirit within the pharmaceutical research community, driving innovations that can lead to improved treatment options for patients.
Conclusion
Reinhold Weidner's contributions to the field of cardiology through his patents on cardiotonic compounds are invaluable. His innovative work continues to pave the way for advancements in the treatment of heart-related diseases, showcasing the importance of dedication and research in the pharmaceutical industry.